Aneuploidy selects for the acquisition of driver genes in breast cancer
New research identifies 90 genes driving basal-like breast cancer, including 81 previously unknown targets linked to aneuploidy.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Coverage concluded that aneuploidy was shown to select for the acquisition of driver genes in breast cancer, and a mouse study identified 90 genes involved in basal‑like disease, 81 of which had not been linked before. Those 81 newly identified genes were presented as potential treatment targets, and the story has since quieted without further reported developments.
Epilogue added 129d ago, after coverage quieted.
The brief
Researchers at Sinai Health have published findings indicating that aneuploidy influences the acquisition of specific driver genes during the progression of breast cancer. The study, detailed in Nature, identifies 90 genes associated with basal-like breast cancer development.
Coverage from Bioengineer.org, Medical Xpress, and EurekAlert! emphasizes that 81 of the identified genes had not previously been connected to the disease. The Telugu Times characterizes the discovery as a potential answer to a long-standing mystery regarding cancer progression.
Future reports may clarify how these 81 new treatment targets can be utilized in clinical settings. Documentation does not yet specify a timeline for potential human trials or the development of therapies based on these genetic markers.
Synthesized by PULSE from the headlines below under a strict no-invention contract. Updated 129d ago.
Quick answers
What is the primary finding of the study?
The study identified 90 genes that drive basal-like breast cancer, 81 of which were not previously linked to the disease.
What role does aneuploidy play in this process?
According to coverage in Nature, aneuploidy selects for the acquisition of these specific driver genes during breast cancer progression.
Where was this research conducted?
The study was conducted at Sinai Health.
Coverage (5)
- A Key Clue in the Cancer Mystery..! Has an Answer to a Long-Standing Question Finally Been Found? Telugu Times · 132d ago
- Aneuploidy Drives Acquisition of Key Genes in Breast Cancer Progression Bioengineer.org · 132d ago
- Sinai Health Mouse Study Has Identified 90 Genes Driving Basal-Like Breast Cancer, 81 of Which Had not Previously Been Linked to the Disease EurekAlert! · 132d ago
- A long‑standing mystery in the deadliest breast cancer just yielded 81 new treatment targets Medical Xpress · 132d ago
- Aneuploidy selects for the acquisition of driver genes in breast cancer Nature · 132d ago
Topics
Related trends
A cellular atlas of the preinvasive breast cancer microenvironment
A new single-cell atlas maps the microenvironment around preinvasive breast cancer, revealing cellular changes that may predict which cases progress to invasive disease.
Roche Secures First U.S. Approval for New Breast-Cancer Pill
Roche wins FDA approval for its first U.S. oral SERD, giredestrant plus everolimus, for hormone-resistant advanced breast cancer.
The Largest Alzheimer's Genetics Study Yet Found 48 New Links. The Most Promising Clue Isn't About Memory
The largest Alzheimer's genetics study yet has uncovered 48 new links, highlighting how genetics and sleep interact.
Iowa ranks No. 2 for young adult cancer cases
Iowa ranks second nationally for young adult cancer cases as new research links rising rates to early detection of prostate and breast cancers while death rates decline.
Not afraid of ghosts: Curiosity and fearlessness apparent in German shepherd genes
A study from Uppsala University and the Swedish University of Agricultural Sciences finds that German shepherds bred for working roles are genetically distinct from show-line dogs, showing more curiosity and less fear.
Exposure to certain ‘forever chemicals’ could heighten risk of aggressive breast cancer, NIH says
NIH-backed research links elevated PFOS blood levels to a 93% higher incidence of ER-negative breast cancer, intensifying scrutiny of forever chemicals.